Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Jul 14

PMID 37444590

Authors

Lawrence L Leung

Timothy Myles

John Morser

Affiliations

Soon will be listed here.

Abstract

Osteopontin (OPN) is a multi-functional protein that is involved in various cellular processes such as cell adhesion, migration, and signaling. There is a single conserved thrombin cleavage site in OPN that, when cleaved, yields two fragments with different properties from full-length OPN. In cancer, OPN has tumor-promoting activity and plays a role in tumor growth and metastasis. High levels of OPN expression in cancer cells and tumor tissue are found in various types of cancer, including breast, lung, prostate, ovarian, colorectal, and pancreatic cancer, and are associated with poor prognosis and decreased survival rates. OPN promotes tumor progression and invasion by stimulating cell proliferation and angiogenesis and also facilitates the metastasis of cancer cells to other parts of the body by promoting cell adhesion and migration. Furthermore, OPN contributes to immune evasion by inhibiting the activity of immune cells. Thrombin cleavage of OPN initiates OPN's tumor-promoting activity, and thrombin cleavage fragments of OPN down-regulate the host immune anti-tumor response.

Citing Articles

The coagulation and tumor system are directly linked through the proteolysis and activation of epidermal growth factor receptor by thrombin.

Wang T, Shen Z, Yang L, Zhang X, Yu M, Yu S Oncogene. 2025; .

PMID: 39910317 DOI: 10.1038/s41388-025-03296-1.

Neural repair function of osteopontin in stroke and stroke‑related diseases (Review).

Sun X, Li C Exp Ther Med. 2024; 28(6):459.

PMID: 39478739 PMC: 11523235. DOI: 10.3892/etm.2024.12749.

Ameliorative effects of sildenafil against carbon tetrachloride induced hepatic fibrosis in rat model through downregulation of osteopontin gene expression.

Nasr H, Hegazy A, El-Shaer N, El-Shafey R, Elgendy S, Elnoury H Sci Rep. 2024; 14(1):16902.

PMID: 39043726 PMC: 11266717. DOI: 10.1038/s41598-024-67305-1.

Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection.

Shete A, Ghate M, Iwasaki-Hozumi H, Patil S, Shidhaye P, Bai G Viruses. 2024; 16(5).

PMID: 38793546 PMC: 11126111. DOI: 10.3390/v16050664.

Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma.

De Re V, Lopci E, Brisotto G, Elia C, Mussolin L, Mascarin M Biomedicines. 2024; 12(1).

PMID: 38275392 PMC: 10813762. DOI: 10.3390/biomedicines12010031.

References

Brown L, Berse B, Manseau E, Tognazzi K, Perruzzi C, Dvorak H . Osteopontin expression and distribution in human carcinomas. Am J Pathol. 1994; 145(3):610-23. PMC: 1890312. View

Rani S, Sehgal A, Kaur J, Pandher D, Punia R . Osteopontin as a Tumor Marker in Ovarian Cancer. J Midlife Health. 2023; 13(3):200-205. PMC: 10025823. DOI: 10.4103/jmh.jmh_52_22. View

Li X, Zhang Q, Chen G, Luo D . Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC and SPP1 TAMs in Cervical Cancer. Front Immunol. 2021; 12:694801. PMC: 8290180. DOI: 10.3389/fimmu.2021.694801. View

Storan M, Heazlewood S, Heazlewood C, Haylock D, Alexander W, Neaves R . Brief Report: Factors Released by Megakaryocytes Thrombin Cleave Osteopontin to Negatively Regulate Hematopoietic Stem Cells. Stem Cells. 2015; 33(7):2351-7. DOI: 10.1002/stem.2038. View

Schytte G, Christensen B, Bregenov I, Sorensen E . Ras-transformation reduce FAM20C expression and osteopontin phosphorylation. Biosci Rep. 2020; 40(9). PMC: 7494989. DOI: 10.1042/BSR20194378. View

Liu Y, Kang B, Chen J . Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells. Oncogene. 2004; 23(1):278-88. DOI: 10.1038/sj.onc.1207022. View

Yang Q, Zhang H, Wei T, Lin A, Sun Y, Luo P . Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes. Front Immunol. 2021; 12:756722. PMC: 8602907. DOI: 10.3389/fimmu.2021.756722. View

Fu Y, Zhang Y, Lei Z, Liu T, Cai T, Wang A . Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J Hematol Oncol. 2020; 13(1):169. PMC: 7720454. DOI: 10.1186/s13045-020-01009-7. View

Li H, Shen H, Yan G, Zhang Y, Liu M, Fang P . Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin. Biochim Biophys Acta. 2014; 1854(6):581-91. DOI: 10.1016/j.bbapap.2014.09.025. View

10.

Chai-Adisaksopha C, Hillis C, Isayama T, Lim W, Iorio A, Crowther M . Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2015; 13(11):2012-20. DOI: 10.1111/jth.13139. View

11.

Niers T, Bruggemann L, Klerk C, Muller F, Buckle T, Reitsma P . Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis. 2008; 26(3):171-8. DOI: 10.1007/s10585-008-9227-6. View

12.

Yokosaki Y, Matsuura N, Sasaki T, Murakami I, Schneider H, Higashiyama S . The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem. 1999; 274(51):36328-34. DOI: 10.1074/jbc.274.51.36328. View

13.

Dai J, Peng L, Fan K, Wang H, Wei R, Ji G . Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene. 2009; 28(38):3412-22. DOI: 10.1038/onc.2009.189. View

14.

Mi Z, Oliver T, Guo H, Gao C, Kuo P . Thrombin-cleaved COOH(-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Cancer Res. 2007; 67(9):4088-97. DOI: 10.1158/0008-5472.CAN-06-4066. View

15.

Gimba E, Brum M, Nestal de Moraes G . Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review). Int J Oncol. 2018; 54(2):420-430. DOI: 10.3892/ijo.2018.4656. View

16.

Zhang Q, Domenicucci C, Goldberg H, Wrana J, Sodek J . Characterization of fetal porcine bone sialoproteins, secreted phosphoprotein I (SPPI, osteopontin), bone sialoprotein, and a 23-kDa glycoprotein. Demonstration that the 23-kDa glycoprotein is derived from the carboxyl terminus of SPPI. J Biol Chem. 1990; 265(13):7583-9. View

17.

Herum K, Romaine A, Wang A, Melleby A, Strand M, Pacheco J . Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin. J Am Heart Assoc. 2020; 9(3):e013518. PMC: 7033859. DOI: 10.1161/JAHA.119.013518. View

18.

Oyama M, Kariya Y, Kariya Y, Matsumoto K, Kanno M, Yamaguchi Y . Biological role of site-specific O-glycosylation in cell adhesion activity and phosphorylation of osteopontin. Biochem J. 2018; 475(9):1583-1595. DOI: 10.1042/BCJ20170205. View

19.

Wang Y, Wang Q, Yu D, Song C, Guo Z, Liu X . Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation. J Cancer Res Clin Oncol. 2021; 147(11):3245-3254. DOI: 10.1007/s00432-021-03731-2. View

20.

Platzer G, Zerko S, Saxena S, Kozminski W, Konrat R . (1)H, (15)N, (13)C resonance assignment of human osteopontin. Biomol NMR Assign. 2015; 9(2):289-92. PMC: 4568010. DOI: 10.1007/s12104-014-9594-7. View